Literature DB >> 35179640

[VEXAS syndrome].

M Zeeck1,2, I Kötter1,2, M Krusche3.   

Abstract

The VEXAS syndrome is a recently identified autoinflammatory systemic disease. The acronym VEXAS stands for Vacuoles, E1 enzyme, X‑linked, Autoinflammatory, Somatic. The disease is due to an acquired somatic mutation of the UBA1 gene, which encodes for the E‑1 enzyme, which in turn is responsible for the ubiquitination of proteins. Due to its location on the X chromosome, the disease predominantly affects men (in the second half of life). The patients present with a plethora of inflammatory clinical symptoms, often with overlap of hematologic, dermatologic, and rheumatologic syndromes. In particular, the presence of cytoplasmic vacuoles in the bone marrow is characteristic. In this article we report the clinical case of a VEXAS patient and give an overview of the pathophysiology, clinical symptoms and diagnostics of the disease.
© 2022. The Author(s).

Entities:  

Keywords:  Autoinflammation; Myelodysplastic syndrome; Polychondritis; Somatic mutation; Vacuoles

Year:  2022        PMID: 35179640     DOI: 10.1007/s00393-022-01169-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  9 in total

1.  Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.

Authors:  Yohei Kirino; Kaoru Takase-Minegishi; Naomi Tsuchida; Lisa Hirahara; Yosuke Kunishita; Ryusuke Yoshimi; Hideaki Nakajima
Journal:  Ann Rheum Dis       Date:  2021-06-21       Impact factor: 19.103

2.  Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.

Authors:  Aurélien Sokal; Thomas de Nadaï; Julien Maquet; Thibault Comont; Nicolas Limal; Marc Michel; Odile Beyne-Rauzy; Bertrand Godeau; Daniel Adoue; Matthieu Mahévas; Guillaume Moulis
Journal:  Br J Haematol       Date:  2021-11-05       Impact factor: 6.998

3.  VEXAS syndrome-related AA amyloidosis: a case report.

Authors:  Romain Euvrard; Thomas Fournier; Dana Georgescu; Estelle Bourbon; Pierre Sujobert; Jean Christophe Lega; Leopold Adelaide
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

4.  Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.

Authors:  S Georgin-Lavialle; B Terrier; A F Guedon; M Heiblig; T Comont; E Lazaro; V Lacombe; L Terriou; S Ardois; J-D Bouaziz; A Mathian; G Le Guenno; A Aouba; R Outh; A Meyer; M Roux-Sauvat; M Ebbo; L P Zhao; A Bigot; Y Jamilloux; V Guillotin; E Flamarion; P Henneton; G Vial; V Jachiet; J Rossignol; S Vinzio; T Weitten; J Vinit; C Deligny; S Humbert; M Samson; N Magy-Bertrand; T Moulinet; R Bourguiba; T Hanslik; C Bachmeyer; M Sebert; M Kostine; B Bienvenu; P Biscay; E Liozon; L Sailler; F Chasset; A Audemard-Verger; E Duroyon; G Sarrabay; F Borlot; C Dieval; T Cluzeau; P Marianetti; H Lobbes; G Boursier; M Gerfaud-Valentin; J Jeannel; A Servettaz; S Audia; M Larue; B Henriot; B Faucher; J Graveleau; B de Sainte Marie; J Galland; L Bouillet; C Arnaud; L Ades; F Carrat; P Hirsch; P Fenaux; O Fain; P Sujobert; O Kosmider; A Mekinian
Journal:  Br J Dermatol       Date:  2021-11-28       Impact factor: 9.302

5.  UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.

Authors:  Eve Zakine; Bérénice Schell; Maxime Battistella; Marie-Dominique Vignon-Pennamen; François Chasset; Thibault Mahévas; Florence Cordoliani; Lionel Adès; Marie Sébert; Jérémie Delaleu; Marie Jachiet; Clémence Lepelletier; Pierre Lemaire; Clémentine Chauvel; Bedis Dhouaieb; Rathana Kim; Charles Cassius; Sophie Georgin-Lavialle; Arsène Mekinian; Martine Bagot; Thorsten Braun; Laurie Rousset; Edouard Begon; Adèle de Masson; Pierre Fenaux; Emmanuelle Clappier; Jean-David Bouaziz
Journal:  JAMA Dermatol       Date:  2021-11-01       Impact factor: 11.816

Review 6.  Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.

Authors:  Keith A Sikora; Kristina V Wells; Ertugrul Cagri Bolek; Adrianna I Jones; Peter C Grayson
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

Review 7.  VEXAS syndrome.

Authors:  Peter C Grayson; Bhavisha A Patel; Neal S Young
Journal:  Blood       Date:  2021-07-01       Impact factor: 25.476

8.  VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.

Authors:  Francesco Muratore; Chiara Marvisi; Paola Castrignanò; Davide Nicoli; Enrico Farnetti; Orsola Bonanno; Rosina Longo; Piera Zaldini; Elena Galli; Nicholas Balanda; David B Beck; Peter C Grayson; Nicolò Pipitone; Luigi Boiardi; Carlo Salvarani
Journal:  Arthritis Rheumatol       Date:  2022-03-03       Impact factor: 15.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.